Show simple item record

dc.contributor.authorPrimahana, Gian
dc.contributor.authorRisdian, Chandra
dc.contributor.authorMozef, Tjandrawati
dc.contributor.authorWink, Joachim
dc.contributor.authorSurup, Frank
dc.contributor.authorStadler, Marc
dc.date.accessioned2021-04-19T13:20:05Z
dc.date.available2021-04-19T13:20:05Z
dc.date.issued2021-03-05
dc.identifier.citationAntibiotics (Basel). 2021 Mar 5;10(3):261. doi: 10.3390/antibiotics10030261.en_US
dc.identifier.issn2079-6382
dc.identifier.pmid33807584
dc.identifier.doi10.3390/antibiotics10030261
dc.identifier.urihttp://hdl.handle.net/10033/622832
dc.description.abstractThe rare actinobacterium Amycolatopsis sp. strain 195334CR was found to produce previously undescribed cyclic hexapeptides, which we named amycolatomycin A and B (1 and 2). Their planar structures were determined by high-resolution mass spectrometry as well as extensive 1D and 2D NMR spectroscopy, while the absolute stereochemistry of its amino acids were determined by Marfey's method. Moreover, 1 and 2 differ by the incorporation of l-Ile and l-allo-Ile, respectively, whose FDVA (Nα-(2,4-Dinitro-5-fluorphenyl)-L-valinamide) derivatives were separated on a C4 column. Their hallmark in common is a unique 2,6-dichloro-tryptophan amino acid unit. Amycolatomycin A (1) exhibited weak activity against Bacillus subtilis DSM 10 (minimum inhibitory concentration (MIC) = 33.4 µg/mL).en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject2,6-dichloro-tryptophanen_US
dc.subjectAmycolatopsis sp.en_US
dc.subjectamycolatomycinsen_US
dc.subjectnew secondary metabolitesen_US
dc.subjectpeptidesen_US
dc.subjectrare Actinobacteriaen_US
dc.titleAmycolatomycins A and B, Cyclic Hexapeptides Isolated from an amycolatopsis sp. 195334CR.en_US
dc.typeArticleen_US
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalAntibiotics (Basel, Switzerland)en_US
dc.source.volume10
dc.source.issue3
refterms.dateFOA2021-04-19T13:20:06Z
dc.source.journaltitleAntibiotics (Basel, Switzerland)
dc.source.countrySwitzerland


Files in this item

Thumbnail
Name:
Primahana et al.pdf
Size:
1.172Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International